Aptar Enters into Agreement with Weihai Hengyu Medical Products
Forward Looking Statements & Non-GAAP Financial Measures
Aptar
Transformative Drug
& Dispensing Sy
ATR TRADES ON THE NYSE
maker with gun sets off Househamber metal detector NEWS
dinto NFC title game without WR Brown ESFIT Kerr: Officials
Aptar
This press release contains forward-looking statements, including regarding the potential acquisition of Hengyu
and the anticipated effects of the acquisition. Expressions or future or conditional verbs such as "will," "would" and
"expects" are intended to identify such forward-looking statements. Forward-looking statements are made
pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934 and are based on our beliefs as well as assumptions made by and information
currently available to us. Accordingly, our actual results may differ materially from those expressed or implied in
such forward-looking statements due to known or unknown risks and uncertainties that exist in our operations and
business environment including, but not limited to: the satisfaction of the conditions to closing the acquisition; the
expected benefits of the acquisition; the successful integration of Hengyu; the regulatory environment; and
competition, including technological advances. For additional information on these and other risks and
uncertainties, please see Aptar's filings with the Securities and Exchange Commission, including the discussion
under "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of
Operations" in Aptar's Form 10-K and Form 10-Qs. Aptar undertakes no obligation to update any forward-looking
statements, whether as a result of new information, future events or otherwise, except as required by law.
ALL T
TIMES
SQUARE
2View entire presentation